Well darn. Now I can’t find the SAE in the slide
Post# of 148133
But yes I pretty much agree with you…
“ Correct me if I’m wrong but I am not aware of any SAE with Leronlimab that was attributed to the drug and not merely associated with the patient by virtue of other treatments;”
I brought up when I saw it last night because folks debated the 1 SAE mentioned in the call. If memory serves, it was gastrointestinal. (Though I can’t find the slide right now) And that strikes me also as a little harsh to signify as an SAE. And if memory serves, this person dropped out of the trial due their gastrointestinal complication.